GL1X · GenesisL1 explorer

MolNFT v1 · #105780 · protein

Crystal structure of double-domain arginine kinase from anthopleura japonicas in complex with L-arginine and atpgs

4RF9: “Crystal structure of double-domain arginine kinase from anthopleura japonicas in complex with L-arginine and…”. X-ray diffraction, 2 ligands (ARG, AGS), 11 pockets (best druggability 0.79). MolNFT v1 #105780 on GenesisL1: 3D…

PDB
4RF9
Type
protein
Length
1,376 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Arginine kinase
EC
2.7.3.3
UniProt
O15992
Ligands
ARG, AGS
Pockets
11 · best druggability 0.79

Structure

x-ray diffraction · 2 distinct chains · 39% helix, 17% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AArginine kinase (EC 2.7.3.3)protein69039% helix, 18% strandO15992
BArginine kinase (EC 2.7.3.3)protein68638% helix, 17% strandO15992

Ligands and binding sites

  • ARG · Arginine · ligand · 2 copies · chains A, B
  • AGS · Phosphothiophosphoric acid-adenylate ester · ligand · chains B
  • ACT · Acetate ion · additive · 2 copies · chains B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

11 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
14170.790.8853empty
210890.740.7797empty
39340.730.7792ACT
41310.430.7619empty
51350.400.7524ARG

Interfaces

1 interface between chains.

  • A–B · 908 Ų buried · 9 hydrogen bonds · protein-protein

Compared structures

  • 4RF9 · Crystal structure of double-domain arginine kinase from Anthopleura japonicas in complex… · the same entry in another collection · chain A against A, TM-score 1.00
  • O15992 · AlphaFold monomer V2.0 prediction for arginine kinase (O15992) · a predicted model of the same protein · chain A against A, TM-score 0.95

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.